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Available online xxxxObjective: Case report and literature review.
Background: Enterococcus faecium is an emerging pathogen responsible for post procedural infections in patients
who have undergone spinal decompression surgery. In this case report, the authors discuss and review recent lit-
erature on approaches to post-operative spinal infection.
Case report:We herein report the case of a 55-year-old HIV-negative Caucasian Italian womanwho showed ver-
tebral osteomyelitis with abscesses around the interbody cage caused by an Enterococcus faecium vancomycin
resistant gen-Van A, following a Transforaminal Lumbar Interbody Fusion (TLIF). The same strain was detected
in disc biopsy, urine culture and rectal swab. After the implant (screws, bars and cage) was removed and a suit-
able medical therapy administered, the infection resolved completely. The strain was identiﬁed and its suscepti-
bility proﬁle was characterized; bioﬁlm-associated genes and bioﬁlm-induced antimicrobial resistance is
highlighted.
Conclusions: In any case, the management of infections complicating spinal surgery is controversial, and various
mono or combined surgical and/or anti-infective timing approaches to remove infected implants have been pro-
posed. The authors suggest a multidisciplinary approach taking into account virulence, microbiological features
of causative pathogens and patient's risk factors. More efforts should be directed towards the early identiﬁcation
of pathogens in surgical specimens.





Transforaminal Lumbar Interbody Fusion (TLIF)1. Background
Surgical site infection (SSI) after spinal surgery is a challengingmed-
ical problem that results in increased rates of morbidity, length of hos-
pital stay and health care costs [1]. The reported incidence of infection
following posterior spinal instrumentation surgery is between 2.6%
and 3.8% [2–6]. Bacteria isolated from disc material are more frequent
in patients with disc herniation than ones with other spinal disorders
[7,8]. Staphylococcus aureus is the most common cause of SSI, although
infections due to Staphylococcus epidermidis, Enterococcus faecalis, Pseu-
domonas spp., Enterobacter cloacae, and Proteus mirabilis have also been
reported [9,10]. The surgical procedure seems to be themost signiﬁcant
variable affecting rate of infection. The risk of infection following ations of interest. No funds were
ntal Biomedicine and Clinical
, University of Palermo, Via del
).
. This is an open access article undersimple lumbar discectomy is b1% due to shorter operative times, less
muscle trauma, and generally healthier patients than those requiring
more extensive spinal procedures. When more extensive decompres-
sion is performed, without fusion, the risk of infection rises to 2%.
When fusion is added to the procedure, operative time is longer and
blood loss is greater. In this case, the infection rate rises to 6%. Other fac-
tors include extended pre-hospitalization, high blood loss (N1000 mL),
and prolonged operative time (N3 h) [11]. (Although rates of infection
are clearly lower in younger patients because of fewer comorbidities,
other signiﬁcant risk factors are: diabetesmellitus, obesity, and a history
of an SSI [2].) Accurate diagnosis is essential in order to effectively erad-
icate the infecting organisms, but this is often difﬁcult to achieve. Specif-
ic clinical signs, laboratory and radiographic investigations that aid
diagnosis of infection may be absent. Inﬂammatory markers together
with the clinical symptoms (low back and radicular pain) should alert
the physician to the possibility of infection [12]. Enterococcus spp. is an
emerging opportunistic pathogen that causes implant-related SSI.
Treatment of enterococcal prosthetic joint infection is difﬁcult, in part
due to bioﬁlm-associated antimicrobial resistance. The antibiotic resis-
tance properties of E. faecium strains have recently been associatedthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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stress, and adhesion to eukaryotic cells, such as those of the urinary
tract [9–11,13]. We report the clinical and surgical management of a
case of disc infection due to Vancomycin Resistant Enterococcus faecium
(VRE) after surgical decompression.
2. Case report
A 55-year-old HIV-negative Caucasian Italianwomanwith fever and
low back pain lasting onemonthwas admitted to our Emergency Surgi-
cal Department in April 2015. Her medical history was remarkable for
hypertension and coronary artery disease. Before treatment, the patient
had had several episodes of urinary tract infection, and a urine culture
resulted in the isolation of Enterococcus spp. susceptible to vancomicin,
gentamicin and ampicillin (minimal inhibitory concentration, MIC for
ampicillin b64 g/ml). Surgical history revealed that the patient had un-
dergone L3–L5 open decompression and a 360° fusion with pedicle
screws in L3–L4–L5 as well as a Peek interbody cage by TLIF in L4–L5
since 8 months prior the admission to our surgical setting, for a severe
low back pain due to L3–L4, L4–L5 instability and diffuse
spondyloarthrosis (Figs. 1–2). A physical examination of the patient at
admission showed fever (temperature, 38.9 °C [102 °F]) and left L3–
L4–L5 radicular hypoesthesia. Initial laboratory studies revealed the fol-
lowing values:white blood cell (WBC) count, 27.3 × 104 cells/mm3 (74%
neutrophils, 10% bands, 10% lymphocytes, and 3% eosinophils); hemo-
globin level, 12.7 g/dL; platelet count, 2.7 × 105 platelets/mm3; serum
creatinine level, 0.9mg/dL; aspartate aminotransferase level, 29 U/L; al-
anine aminotransferase level, 27 U/L; total bilirubin level, 1.5mg/dL; in-
direct bilirubin level, 0.5 mg/dL; and lactate dehydrogenase level,
2900 U/L. A lumbar puncture was performed. The opening pressure
was 15 mm Hg, and analysis of cerebrospinal ﬂuid (CSF) revealed the
following values: WBC count, 28 cells/mm3; glucose level, 58 mg/dL;
and protein level, 19 mg/dL. Microscopic examinations, aerobic and an-
aerobic bacterial cultures aswell as acid-fast bacillus test (AFB) and fun-
gal cultures to identify pathogens in the CSF were negative; polymerase
chain reaction (PCR) tests for relevant viral and bacterial infectious
agents such as Mycobacterium tuberculosis were negative. Moreover,
bacterial cultures and other analyses for other pathogens which are ep-
idemiologically relevant in our geographic area (e.g. Rickettsia conorii,
Brucella spp.) were negative, as previously reported in another case of
suspected infection involving the CNS [14]. A Lumbar CT scan showedFig. 1. Pre-operative lumbar MRI. A. Sagittal view. A diffuse spondyloarthrosis, with
herniated discs in L3–L4 and microinstability at L4–L5 is documented. B Axial view. The
L3–L4 level is depicted.areas of bone remodeling with sclerotic margins at both L4 and L5, so-
matic cortical proﬁles consistent with an inﬂammatory process (Fig.
3A–B). A Magnetic Resonance Imaging (MRI) of the lumbar sacral
tract conﬁrmed osteomyelitis of the L3–L4–L5 bodies, especially around
the cage at the L4–L5 interbody level. The infection seemed to reach the
screws in the L4–L5 body and the left paravertebral region; there was
another quota of pathological tissue both in the prevertebral L5 and in
the subcutaneous space, with 8 cm extended ﬂuid collection (Fig. 3C–
D). The results of blood, urine and ﬂuid sample cultures were negative.
Therefore, a medical therapy with intravenous cefuroxime (140 mg/kg
per day) and vancomycin (2 g/day) for suspected vertebral osteomyeli-
tis, was administered. On day 18 of hospitalization, the patient became
febrile (temperature, 39.4 °C [103 °F]) without clinical manifestations of
sepsis or other suspected focus of infection. A transthoracic echocardio-
gram showed no valvular abnormality or vegetation. A head CT scan
without contrast was unremarkable. Culture of blood and urine were
performed. Enterococcus faecium strain was isolated from the urine cul-
ture. It was resistant to ampicillin (MIC ≥64 μg/ml) and vancomycin
(MIC of minimum inhibitory concentration ≥ 256 μg/ml), and exhibited
high-level resistance to aminoglycosides (high-level resistance to gen-
tamicin was tested for using the 120 μg gentamicin disc) and suscepti-
bility to rifampin, daptomycin, tygeciclyne and linezolid [15,16]. The
patient was given rifampicin and daptomycin for possible systemic En-
terococcus faecium infection. The same resistant strainwas isolated from
the patient's rectal swab. A persistent fever over the following days
prompted ourmultidisciplinary neurosurgical and infection team to de-
velop a surgical strategy. Therefore, a surgical lumbar wound explora-
tion was performed; instrumentation was all removed and a wound
debridement was carried out. Once completed, ﬁbrin sealant
(Vivostat®) was sprayed on the operative ﬁeld, in order to prevent
CSF leakage [17–23]. Disc biopsy culture identiﬁed Enterococcus faecium.
The isolate showed the same susceptibility proﬁle as the strain isolated
from the urine culture. At discharge, 6 months of oral antibiotic therapy
with Linezolid plus Rifampicin plus Doxycyclin was prescribed. After six
months of anti-infective treatment, MRI investigations showed that the
inﬂammatory disease had progressively resolved (Fig. 4). At the ﬁnal
follow up the neurologic examination was unremarkable. No motor or
sensory deﬁcit was evident. Patient referred just low back pain which
was signiﬁcantly lower than pre operatory status. Analysis of E. faecium
strains isolated from disc biopsy, rectal swab and urine culture by PCR
ampliﬁcation revealed the presence of the vanA gene [15]. A new poste-
rior transpedicle ﬁxation to correct lumbar segmental instability has
been proposed to the patient but she has actually refused.
3. Discussion
In 2014, scientiﬁc literature addressed the issue of instrumentation
removal or retention in the attempt to reduce infection following spinal
surgical procedures, especially after Posterior/Transforaminal Lumbar
Interbody Fusion [16,24,25]. The management of infections is currently
under debate because, as reported byWei-Hua et al., it is likely that the
implants do not interfere with the body's attempt to ﬁght infection, es-
pecially precocious infection [25]. The more complicated procedures
and more reconstruction levels involved in fusion surgery with instru-
mentation may explain the higher revision and mortality rates [26,27].
In this manuscript the authors describe and discuss the role of Entero-
coccus faecium as an emerging pathogen responsible for vertebral oste-
omyelitis after spinal surgery. Enterococci occur naturally among the
normal ﬂora in the human gastrointestinal tract. Initially thought to be
harmless commensal organisms in hospitalized patients, enterococci
have emerged as signiﬁcant nosocomial pathogens. At present, Entero-
cocci are known to be the cause of important nosocomial infections such
as endocarditis, bacteremia and urinary tract infections, especially in el-
derly female patients [28]. Enterococci are intrinsically resistant to sev-
eral antibiotics and possess the ability to acquire resistance through the
exchange of genetic material [29]. As a result, they have become more
Fig. 2. Post-operative lumbar CT scan. Pedicle screws in L3, L4 and L5 bilaterally and intersomatic L4–L5 cage by TLIF.
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tibiotic Resistance Surveillance System, an international network that
collects data on antibiotic resistance of bloodstream-infecting isolates
in 28 European countries (http://www.earss.rivm.nl/), in Italy the pro-
portion of VRE was higher than 10% in 2001 and 2015. Colonization
and infection with vancomycin-resistant enterococci are associated
with prolonged hospitalization, exposure to cephalosporins and vanco-
mycin, and the use of antianaerobic agents [30]. Compared to Enterococ-
cus faecalis, E. faecium isolates are more resistant to penicillin, and large
molecules such as nafcillin, oxacillin, ticarcillin, ertapenem, most ceph-
alosporins, and aztreonam. Moreover E. faecium is more impermeableFig. 3.A–B: Post operative CT scan (8months). An area of bone remodeling in both L4 and L5 som
weighted sagittal images. D. T1 weighted, post contrast MRI. Lumbar enhanced MRI scan r
paravertebral L3–L5 region. All these ﬁndings were suggestive of surgical site infection. (For i
web version of this article.)to aminoglycosides, and the serum concentrations of aminoglycosides
required for bactericidal activity are much higher than other pathogens
[29–32]. Two hospital outbreaks have been reported in Italy in the last
decade; one was due to VRE belonging to the species Enterococcus
faecalis (VRE) in a neurosurgical ICU [29]. Management of post-opera-
tive spinal infection is controversial, and various treatment options
have been proposed: some advocate medical therapy only, some sug-
gest irrigation and serial wound debridement plus antibiotic therapy,
while others report that infection can be eradicated only by removing
implants [25–27]. Chaichana et al. retrospectively reviewed 817 consec-
utive adult patients who underwent instrumented posterior lumbaratic cortical proﬁles (orange arrow) is depicted C–DPost operative lumbarMRI scan. C. T2
evealed a pathological enhancement in vertebral bodies of L4, L5, vertebral canal and
nterpretation of the references to color in this ﬁgure legend, the reader is referred to the
Fig. 4. Post-medical treatment lumbarMRI. Sixmonths after anti-infective treatment, MRI
showed a progressive resolution of infection.
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817 pts, 37 (4.5%) developed postoperative spine infection [12].
Because patterns of infection acquired in patients undergoing oper-
ation are ever changing, it is an essential part of nosocomial infection
surveillance programs to periodically document the epidemiologic fea-
tures of infection in these patients [33]. Table 1 reassume old and new
risk factor for infection following neurosurgery procedure [2,34–38].
Bioﬁlm formation is a crucial step in the pathogenesis of many sub-
acute and chronic bacterial infections, including methicillin-resistant
Staphylococcus aureus (MRSA), methicillin-sensitive S. aureus (MSSA),
Candida species, and Enterococcus species foreign body-related
infections.
There is general consensus that the adhesion ofmicrobes to a surface
inﬂuences bacterial metabolism, like microorganisms involved in de-
vice-related infection: they are in a dormant, that is a stationary phase
of growth, and the analysis of their growth reports increased bioﬁlm
growth rates in comparison to the effects of efﬂuents on planktonic
growth activity (1). Parsek and Singh (2)were theﬁrst to attempt to de-
ﬁne the signiﬁcance of bioﬁlm infection. Like other scholars, they recog-
nized the consequences of bioﬁlm formation by bacteria, especially in
surgery (3, 4). Today the main problem for the microbiologist remains
bioﬁlm identiﬁcation, which requires particularly sophisticatedTable 1
Risk factors for Enterococcus spp. infection in adult patients in a neurosurgery setting.
Increased risk Emerging risk factors
Age (≥70 years) History of urinary tract infection
Sex, female Emergence of regional clones of Enterococcus faecium
Diabetes Vancomycin-resistant Enterococcus (VRE) colonization
Hematologic malignancy Number of VRE-colonized patients on the unit
Solid tumor Transferred from rehabilitation facilities and
long-term care facilities
Steroid therapy Polymicrobial infection
Previous hospitalization Type of surgery: genitoperineal surgeries
Length of stay in hospital Admission for other surgical pathology (wound
infection, enteric peritonitis)




Exchange (one or two
stage)
Overweight (BMI between 25.0 and 29.9)
Median (IQR) of antibiotic
treatment
Obesity (BMI of 30 or
higher)morphological techniques such as microscopy or ﬂuorescence in situ
hybridization (FISH), as often neither culture nor biomolecular investi-
gations are helpful (5, 6). Obviously antibiotics have limited efﬁcacy
on implant-associated infection because not all antibiotics can over-
come the bioﬁlm in sufﬁcient quantities to clear the microorganism,
hence some studies have looked at combined treatment options (infec-
tious and surgical management) to avoid infection [39–45]. Recent re-
search has shown how some bacterial species, such as enterococcus,
are able to enter bone cells and induce osteoblast apoptosis, osteoclast
recruitment, and highly destructive osteomyelitis [46]. Bioﬁlm forma-
tion in the pathogenesis of enterococcal infections is nowwidely recog-
nized and underscores the importance of taking the pathogenesis of
bioﬁlm infections into considerationwhen comparing themanagement
of postoperative infection due to strain bioﬁlm-associated genes and
bioﬁlm-induced antimicrobial resistance after spinal instrumentation
[47].
This controversial aspect, especially in enterococal infection, should
be solvedwith appropriate controlled studies. In our case report, the de-
cision to remove instrumentation led to the resolution of the infection.
Information on the strain, its susceptibility proﬁle, vancomycin geno-
type and clonal relationship were collected for our clinical information,
and represent the goal of bioﬁlm associated pathogens causative of im-
plant-related infections. Cost-effective analysis should be conducted in
subsequent studies to determine the costs involved in the prevention
of invasive VRE infections in the surgical setting: implementation of ac-
tive surveillance culture, VRE decolonization and probiotics should be
studied further.
4. Conclusion
A delayed infection after instrumented spine surgery can be difﬁcult
to diagnose. We report a very rare surgical site infection due to Entero-
coccus faecium following a urinary tract infection. Effective treatment
usually includes irrigation and wound debridement, followed by
prolonged administration of antibiotics and, in severe cases, by the re-
moval of the implants. However, if the infection is not deep, probably
the instrumentation can be left in place. Bacterial bioﬁlm formation is
central in the pathogenesis of infections related to foreign material,
and E. faecalis and E. faecium can form bioﬁlm. Therefore, considering
that there is no clear consensus on how to manage patients with post-
operative instrumented spinal infection, currently the best choice of
treatment should be made case-by-case.
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